Evofem Biosciences, Inc. announced the appointment of Lisa Rarick, M.D., F.A.C.O.G., to its Board of Directors. Her final year at the FDA was spent in the Office of Women's Health, where she focused on HIV prevention, pregnancy prevention, pre- and post-pregnancy care and menopausal therapy. She is currently a reproductive health and regulatory affairs consultant who has helped numerous companies navigate the development of their products from early-stage development through FDA approval.